Literature DB >> 2459267

Decay-accelerating factor in human skin is associated with elastic fibers.

V P Werth1, I E Ivanov, V Nussenzweig.   

Abstract

Recently a complement inhibitor, decay-accelerating factor (DAF), has been found in association with uncharacterized fibers in the extracellular matrix of human dermis. Here we show by immunohistochemistry and immunoelectronmicroscopy that DAF is on the periphery of elastic fibers, and that it appears to be associated with some microfibrillar elements that cover the fibers. That DAF is a component of these microfibrils is also suggested by studies of lesional skin from anetoderma, a disease characterized by destruction of elastic fibers. In two patients we found a network of residual fine fibers in the dermis that stain with antibodies against DAF and fibrillin (one of the proteins known to be present in the microfibrils of elastin), but do not stain with antibodies to elastin. Western blot analysis of dermal extracts with monoclonal antibodies to DAF identified a 67 kDa molecule, slightly smaller than membrane DAF, and similar in size to soluble DAF found in secretions. It is possible that together with vitronectin, an inhibitor of the membrane attack complex recently identified in association with elastin, DAF prevents damage of elastic fibers by complement.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459267     DOI: 10.1111/1523-1747.ep12476743

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Authors:  K A Gelderman; H J M A A Zijlmans; M J Vonk; A Gorter
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

3.  Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.

Authors:  K Sayama; S Shiraishi; Y Shirakata; Y Kobayashi; N Okada; H Okada; Y Miki
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction.

Authors:  A Zimmermann; H Gerber; V Nussenzweig; H Isliker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 5.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

6.  Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.

Authors:  C N Metz; P Thomas; M A Davitz
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

7.  Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Koei Yamada; Gary S Gilkeson; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

8.  Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Xiujun Sun; Hong Yuan Luo; Dewei Cai; Victoria P Werth; Michael P Madaio; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 9.  Complement system in dermatological diseases - fire under the skin.

Authors:  Jaana Panelius; Seppo Meri
Journal:  Front Med (Lausanne)       Date:  2015-01-29

10.  Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.

Authors:  K Koretz; S Brüderlein; C Henne; P Möller
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.